TGFB1 and central nervous system cancer: IDH1-mutations, present in the GII-III cohort here, were shown to negatively regulate Wnt/β-catenin signaling [89] and TGF-β expression is lower in IDH-mutant compared to IDH-wildtype gliomas [90].